Serotonin Reuptake Inhibitors: Citalopram, Escitalopram, Fluoxetine, Fluvoxamine, Paroxetine, and Sertraline
Author:
- 3 September 2021
- book chapter
- Published by Springer Nature
- p. 1-13
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Is the significant superiority of escitalopram compared with other antidepressants clinically relevant?International Clinical Psychopharmacology, 2009
- Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorderInternational Clinical Psychopharmacology, 2005
- ParoxetineDrugs, 2002
- Clinical Pharmacokinetics of SertralineClinical Pharmacokinetics, 2002
- SertralineDrugs & Aging, 2002
- A Double-Blind, Multicenter Study in Primary Care Comparing Paroxetine and Clomipramine in Patients With Depression and Associated AnxietyThe Journal of Clinical Psychiatry, 1997
- FluvoxamineDrugs, 1993
- Double-Blind Multicenter Study of Paroxetine and Amitriptyline in Depressed InpatientsPharmacopsychiatry, 1993
- Randomized Double-Blind Study of Fluvoxamine and Maprotiline in Treatment of DepressionPharmacopsychiatry, 1991
- FluoxetineDrugs, 1986